Skip to main navigation Skip to search Skip to main content

Rosiglitazone does not improve vascular function in subjects with chronic kidney disease

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)3543–3549
JournalNephrology Dialysis Transplantation
Volume26
DOIs
Publication statusPublished - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this